跳至主要内容
临床试验/CTRI/2020/04/024815
CTRI/2020/04/024815尚未招募未知

esion reduction on whole body MRI in disseminated cysticercosis after 2 weeks of albendazole -A Pilot Study

Kinzang Wangda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All the cases of disseminated cyscticercosis.
  • Patients of neurocysticercosis will be diagnosed on the basis of Del Brutto criteria.
  • Disseminated cysticercosis will be diagnosed as presence of multiple, (three or more than three) cystic viable lesions in the brain along with involvement of an additional extra site.

排除标准

  • Patient in cysticercal encephalitis.
  • The patients having evidence of systemic illness such as primary malignancy,HIV,Hepatitis B and C virus, pulmonary and systemic tuberculosis.
  • Patients/ attendants refusing consent.

研究者

发起方
Kinzang Wangda

相似试验